Target intelligence / Profile preview

H3 histone pseudogene 29 (H3P29)

Target: H3P29
Molecular classification: Other (Pseudogene)

Overview

H3 histone pseudogene 29 (H3P29, also called p41) is a pseudogene and does not encode a functional protein product[2]. It is designated as a histone H3-related sequence but, like other pseudogenes in the genome, it is non-coding and does not produce the main histone H3 protein or any histone H3 variant[2][3]. Histone H3 itself is an essential nucleosomal core protein involved in packaging DNA and regulating gene expression through epigenetic modification, but pseudogenes like H3P29 lack biological activity[1]. There is no evidence that H3P29 is a therapeutic target, has disease relevance, is targeted by drugs, or possesses biomarker or safety concern status.

Other names: p41

Beyond the preview

Go deeper on H3 histone pseudogene 29 (H3P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H3 histone pseudogene 29 (H3P29).

Explore the full profile